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- 
As the population cwlinues lo age, physicians are presenled 
with the challenge of treating a variety of medical conditions 
in elderly patients. Suptaventricular tachycardias are the 
most common form of cardiac arrhythmia and a.lTect all age 
groups (I). Although usually well tolerated in youth. su- 
praventriculw tachycardias may be associated with disabling 
symptoms and have lie-threatening potential in the elderly. 
In additiou, anliarrhylhmic agents are less well tolerated and 
may be associated with a higher incidence of toxicity in this 
age group. 
The purpose of this study was lo 1) evaluate the &xcy 
and wfety of radiofrequency calbeter ablation for tbc treat- 
ment of supmventricular lachycudia in an elderly (80 
years of a& patient group: 2) compare these results with 
those in patients <70 years of age; and 3) determine the 
etTect of ablation on subsequent arrhythmia-related hospital 
care. 
Methods 
From May 1989 to March 1993.454 patients underwent 
radiofrequency catheter ablation at the University of Cali- 
fornia, San Francisco, for the treatment of symptomatic 
supmventricular tachycardia. Sixty-seven of these patients 
we= 270 yEaR Of age and fotwilute the study p0pUkiW. 
Patients underwent one of the following catheter ablation 
procedures: complete altioventricular (AVI junctional able- 
tion for ventricular rate control in patients with atrial tibril- 
lation, AV node modification for the treatment of AV node 
reentrant tachycardia, accessory pathway ablation, ablation 
of the “slow zone” of conduction to cure atrial flutter and coronary artery disease (I:%). and three had a history of 
ectopic atrial tachycardia ablation. One patient underwent hypertension (33%). Mean ejection fraction in this group was 
ablation for both AV node reentrant tachycxdia and atrial 60%. A!I panants were severely symptomatic and presented 
flutter. Arrhythmia-related hospitalizations and emergency with syncope (two patiws), presyncope (six patienls) and 
room visits were compared for each group before and after congeslive heart failure requiring hospital admission (one 
the ablation procedure. Nineteen of the patients undergoing patient1 
AV junctional ablation and two of the patients undergoing Four patient. underwent ablation for the treatment of 
AV node modification have been included in two previous atrial flutter (mean age 77 2 4.3 years, range 71 to 81; one 
reports describing these techniques (2.3). They are described man. three women). These patients were resistant to or 
here as oart of a consecutive series of aatients. with soecific intolerant of a mean of 3.8 f 0.5 antiarrhvthmic medications. 
attention to the effects of advanced ke on the s&y and Concomitant organic heart disease was fbund in two patients 
efficacy of these procedures. (50%) and included coronary artery disease and diastolic 
For purposes of comparison we included patients <7O dysfunction. All patients were symptomatic: fatigue and 
years of age from our previously reported experience. who palpitations (two patients) and presyncope (two patients). 
underwent complete AQjunctional ablation (35 patients) (2): .4trial tachycardia ablation was pelfarmed in a 73-year 
AV node modification (33 Patients) (3) and wessorv oath- old woman with five failed antiarrhythmic medications and 
way ablation (100 patientsj(4) during the same time ~&iod. ao underlying cardiomyopathy (eje&ion fraction JO%). Epi- 
Patient cbaraeteristia. Complete AV junctional ablation sodes of atrial tachycardia precipitated congestive heart 
was perfomted in 37 patients with atrial fibrillation and a failure on several occasions and cardiac arrest on one 
rapid ventricular response that did not respond to medical occasion. 
management (mean [+SDI age 76 5 5 years. range 70 to 85: Diagnostic et~t~hy~~ study. All experimental pro- 
I7 men. 20 women). These oatients were resiasr to or tocols sere approved by the institutional revieew board of the 
intokrantofameanof5. I -c I:3 antiarrhythmic medications. University of Califo&, San Francisco. and written in- 
Concomitant organic heart disease was found in 87% of formed consent was obtnined from all patients. In all pa- 
these patients and included coronary artery disease/ tients. except those undergoing complete AV junctional 
myocardii infarction. rheumatic heart disease and idio- ablation. a standard diagnostic electrophysiologic study was 
pathic dilated cardiomyowtby, The remaining five patients performed before catheter ablation. dwing the same proce- 
(13%) had a history of hypertension. Mean ejection frdction dure. Electrode catheters were wsitioned in the hi& right 
in this group was 50 + 12.6%. and all were severely atrium, right ventricular apex, low septal right atrium and 
symptomatic: syncope (8 patients), presyncope (14 patients). coronary sinus. Atrial and ventricular incremental pacing 
congestive hearc ftilwe requiring hospital stay (14 patients) and programmed extrastimulation was performed. Isoproter- 
and car&c arrest (I patient). enol was given if supnventricular tachycxdia could not be 
Atrioventricuku node modification was aerformed in I7 induced at baseline. Standard criteria for determining the 
oatients with AV node reentrant tachycaidia (mean age mechanisms of the supraventricular tachycardias were-used 
ib.8 2 6.3 yews, range 70 to 93: 7 men. 10 women). one (5). 
wtient also had svmotomatic atrial Butter and underwent Ablation procedures. At attempted ablation sites. 20 to 
&ative atrial i&r ablation in addition to AV node modi- 50 W of unn&Julated radiof?equency energy (EP Technolo- 
hation (see later). These patients were resistant to or gies) was delivered between the distal electrode of the 
intdetantofamettn of4.3 t 1.4antiarrhythmic medications. ablation catheter and a large-diameter skin patch electrode. 
Concomitant organic heart disease was found in 33% of Unless otherwise noted, a 7F or 8F tipdeflecting bipolar or 
these patients and included coronary artery disease, atria1 quadmpolar catheter with a 4. or S-mm distal electrode (EP 
satal defect and mitral valve orolaose. In addition. 33% of Technolocies or Mansfield/Webster) was used as the abla- 
patients had a history of hype~ensi~n. Mean ejectbo frac- tion catheter. 
lion in this group was 57.1 + ‘.7%. All patients were Alrioventricular jun&nal ablation. A standard 6F bipo- 
severely symptomatic: syacope (2 patients), presyncop- (I3 lar electrode catheter was introduced through the right 
patients) and congestive heart failure requiring hospital femoral vein and advanced to the apex of the right ventricle 
admission (2 t&ems). to serve as a temporary pacemaker. As previously described 
Ablation dfan accessory AV pathway was performed in (2). an ablation catheter was also introduced through the 
nine patients (mean age 72.7 c 2.8 years. iange 70 to 77; right femoral vein and advanced across the tricuspid annulus 
three men. six women). These patients were resistant to or to the region of the His bundle. Before October 1990. in the 
intolerant ofa mean of 4. I -C 0.0 antiarrhythmic medications. initial 16 patwnts a custon~, non-tip-deflecting ablation cath- 
Accesson, oathwav conduction was manifest in seven pa- eter with a 3.mm distal electrode was used. Ablation was 
tients and &e&d in two. Disopyramide therapy resulied attempted at the site recording the maximal His bundle 
in cardiac arrest due to polymorphous ventricular tachycar- 
dia in one patient. and encainide therapy resulted in ventric- 
ular tachycardia in another. One patient had concomitant 
potential, with a procedural end point ofcomplete AV biock. 
If complete AV block was maintained for 30 min the patient 
was redraped and prepared, and a permanent pacemaker 
was implanted. Before 1991, ifcomplete AV block could not 
be achieved with radiofrequency energy, ablation with direct 
current energy was attempted, as previously described (2). 
Alrlnventrkular @ode modIli&nu. In the initial live pa- 
tients with AV node reentrant tachycardia, selective ablation 
of the fast AV node pathway was pafomwl, as previously 
described (6). Procedural end points were the noniuducibil- 
ityofAV node reenttant tachycardiaand aH)%prolongation 
of the PR interval or retrograde ventriculoahial block, or 
both. 
In the subsequent 12 patients, selective ablation of the 
slow AV node pathway was performed (3). The procedural 
end point was either absence of evidence of dual AV node 
physiology attd no AV node reentrant echw or alteration of 
slow pathway conduction such that no more than a single 
AV node reentrant echo was present. 
Aewwry pathway nbMbu. After determination of the 
sites in the right atrium. Endocardial activation at each site 
was compared with the onset of the P wave recorded on the 
surface leads. Procedural end points were the termination of 
atrial tachycardia with energy application and the noninduc- 
ibiitv of tachyadia despite atrial overdrive pacing (to cycle 
length 100 m$ and prog&med stimulation (up to-two atrial 
extrastimuli) in the presence and absence of isapmterenol. 
approximate location of the accessory pathway, the ablation 
catheter was positioned rdonn the mitral or tricuspid annu- 
Ius, BE previ&ly dercribed(4). For left-sided &cessory 
pathways, the mitral annulus was reached using a retro@adc 
arterial approach, with the ablation catheter positioned on 
the ventricular side of the mitral valve apparatus, or a 
transeptrdapproach, withtheablation catheterpositioned on 
the atrird aspect of the mitral annulus. During mapping and 
ablation in the systemic circulation, patients &e-&ent full 
anticougulation with intravenous heparin. For tight-sided 
access&y pathways, u transvenou~ approach t&ugh a
femoral vein was used to position the catheter on the attial 
wect of the tricuspid annulus. Ablation was attempted at 
siies that recorded ihe shortest ventrictdnr to atrial’activa- 
lion times during orthodmmic reciprocating tachycardii or 
fusion of the local atrial and ventricular electrograms during 
sinus rhythm, or both, in patients with ventricular pn- 
excitation. Procedural end points were the elimination of 
both anterogrude and retmgrade accessory pathway conduc- 
tion. 
AtrIal Ilulter nhktkm. In four patients. type I (classic) 
atrial flutter wns diamtosed durine the baseline studv 17.8). 
The site of ablation &s determined anntomically &g’ri&t 
and left anterior oblique Ruoroscopic projections. Initial 
ablation attempts were made in the posterior septal space in 
the region between the ostium of the coronary sinus and 
septnl leaflet of the tricuspid valve. If unsuccessful, the 
ablation catheter was repositioned to the postemlateral right 
atrium, in the region between the inferior vcnn cavn and 
tricuspid annulus, and abiation was reattempted. Procedural 
end points were the termination of tachycardia with energy 
andication and the noninducibilitv of atrial flutter desoite 
&al overdrive pacing (to cycle length 100 ms) and pro- 
grammed stimulation (up to two attial extrastimuli) in the 
presence and absence of isoproterenol. 
AtrW tachycardka b~tino. After diagnostic study in the 
one patient with r&l tachycwdia. mapping was perfornaed 
with the ablation catheter during atrial tachycardia to deter- 
mine the onset of endocardinl atrial activation at various 
F&low-up. After the ablation procedure all patients were 
admitted ovemight to a telemeCry unit and underwent con- 
tinuous ekctrocardiographic (ECG) monitoring for at least 
24 h. All patients had a padischarge echocardiogram and 
12-M ECG; 24h ambulatory ECG monitoring v/as per- 
formed --I month after the ablation procedure. 
SuLaierl rBelh&. values are reported as rtlcan value * 
SD. Statistical analysis was performed using analysis of 
variance and chiaquare analysis. and p L 0.05 was consid- 
ered significant. 
ReMllts 
AtrIweWkalu ImwtImal abIM&m. Cosulete heart 
block war achieved b all 37 patients ucdergoi& AV junc- 
tional ablation. In 34 patients (92461, mdiincy energy 
alone was used. A mean of 4.2 2 3.2 mdiitiwuenc~ 
applications were delivered in these patients. Early io Wr 
experience direct current energy was requ&d in three 
patients (6%). There were uo complications at th+ time &he 
ablatiou procedure, and there were no early deaths (within 1 
month of the ah&tion prwdure). In &dditiM. echocardi~ 
gmmr perfwmcd before ho&+itaI discharge rcveakd ml new 
v&ular or myocmdiai abwmalities. Gne patient had a 
nonfatal puImonary embolus 3 days 8flcr hospital discbarge. 
Therefore, the ovemll ¶uccess rate was 10096. with a Eom- 
plication rate of 3%. 
Tllere were four deaths (11%). acurring at a mean of 
24 t IO months alter the ablation procedure. Two patients 
died of pmstate cancer; one patient had a fatal ccrebmvas- 
cular a&lent: and one patient was found dead at home. 
Themfore, a cardiac cause of death may have been present 
in only one patient (2.7%). The remaining 34 fatients (I@%) 
had P mean folhwup of25.3 * 10.6 months (runge 8 to 52). 
Atrioventdcular conduction returned in one patient (3%). 
but the fentticular response WIU signitiwtly slower then 
hefore ablation. These patients all report improved quality of 
lie and are no longer taking sntiarrhythmic agents for the 
control of ventricular note. 
In a recent repoti we descrihcd our experience in patknts 
undergoing AV junctional ablation using direct current and 
radiofrequency energy (2). Radiofrequeney was the initial 
energy choice in 54 patients. Gf this group, 19 patients were 
270 years of age and are included in the results dewihed 
cwlier. The remaining 35 younger patients formed the con- 
trol group (Table I), and the study group was signiticantly 
olde; than the control group (75.6 + 4.5 vs. 51.9 + 13.7 
years, p = O.twJI). However, there were no diiTerences with 
respect to gender, number o: antiarrhythmic agents tried. 
ejection fraction, success utilizing radiofrequency energy. 
number of radiofrequency applications required or compli- 
cations between the two groups. Three patients died, and 
conduction retortted in two patients in the contml group 
duriw follow-up. This was similar to the results in the study 
kmi 
cnrauve #)lrdlm for ttwdment of sop~ven~~ 
~&~ardia. An ablative procedure to cure supraventricular 
tachycardia WBS attempted in 30 patients. The overall SK- 
cess rate was 97% (30 of 31 orocedwes in 29 of 30 ratients). 
There were no p~edo&lated deaths, and thi overall 
complication rate ~85 13% (4 of 30 patients). The details of 
each pnxedore are presented next. 
Abkratrln3rmde t&if&&m. Atrioventticular node 
reentmttt tachycardia was cured in all 17 patients undergoing 
AV oode mod&&n. In the first five patients. successful 
selective ablmion of the fast AV node &way was achieved 
with a mean of 5.8 f 4.9 radiofrequ&cy applications. All 
five Datients had resttltrmt tirst-deeree AV block. In fhe 
subs&tent 12 pr&nts, selective &don of the slow AV 
weal pathway was achieved in II patients with a mean of 
5.6 + 6.6 radiofrequency energy applications. In the one 
remaining prdient a vcntrictdar triplet during energy applica- 
tion caused Ihc ablation catheter to move abruptly to the His 
bundle region. Although the energy application was imme- 
diaelv temtinsted. comoletc heart bkxk was uroduced. 
lIten were no other m~plications or early deaths. There- 
fore. control of arrhythmia was achieved in IW% of patients, 
with a sttccess mte of 94% and a complication rate of 6%. 
One patient with severe chronic obstructive pulmonary 
disease died of nspimtory arrest unrelated to cardiac dis- 
ease 38 months after his ablation pmcedure. Before death 
tlte patient reported 110 arrhythmia recurrences and was not 
&king arty mdiarrhytbmic agents. The remaining I6 patients 
(94%j had a mean follow-up of 19.3 t 15.5 months (range 5 
to 50). The oetient with complete heart block had a dual- 
&m&r, pe&ent pacem&r implanted on the day of his 
ablation pmcedere sod repons no symptoms or limitations 
dariog follow-up. The remaining patients all report improved 
quality of life. no arrhythmia recurrences and are not taking 
any sntiarrhyfhmic agent 
In a recent report we described our results in 35 patients 
undergoing selective ablation of the slow AV node pathway 
for the treatment of AV node ~centram tachycwdia (3). Two 
of these patients were described earlier. The remaining 33 
patients served as the control group (Table 2). The study 
group was significantly older than the control group (76. I 2 
4.7 vs. 43.2 + IS. p = O.CGQl). In addition. the study group 
received significantly more antiarrhythmic medications 
(4.3 ? 1.4 vi. 2.0 C i.0, p = 0.0001). The two groups were 
similar with regard to gender, success, number of radiofre- 
quency applications required, complications. recurrences 
and deaths during follow-up. 
Accessory pathway shlatieo. Successful ablation of a sin- 
gle accessory pathway was achieved in all nine patients with 
a mean of lo.0 f 9.0 radiofrequency energy applications. 
Seven patients had lefi free wail accessory pathways (live 
lateral, two anterolaterall, and two patients had septal ac- 
cessory pathways (one right posteroseptal, one letI interme- 
diate septol). In the eight patients with left-sided pathways, 
a transseptal approach wes utilized in six and a retrograde 
aortic approach in two. There were two procedure-related 
complications. One 74.year old man undergoing ablation of a 
left-sided accessary pathway through a tmnssepti approach 
developed B pericardial effusion with early signs of cardiac 
tampanade immediately after the procedure. A pericardio- 
centesis was performed. and the patient made an uneventful 
recovery. In lhis patient technical difficulties led to extensive 
manipulation of the right ventricular catheter. In addition. 
one 70.year old woman. alsa undergoing ablation of a 
left-sided accessory pathway through a transseptal ap 
praach. developed pericardird pain and a new rub after the 
procedure. Echocardiography revealed no pericardial etlu- 
sion, and the patient had an uneventful recovery. There were 
no early deaths in this patient group. Therefore. the overall 
success nte was IW%. with B major complication rate of 
II% and an overall complication &te of 22%. 
There have been no deaths or recurrences of accessory 
pathway conduction during B mean fallow-up period d I4 + 
9 manths (range 5 to 27). Two patients have continued 
antiarrhythmic medications (quinidine in one, amiadamne in 
one) for the treatment of atrial fibrillation. All patients report 
significantly improved qualily of life. 
In B recent report we described our experience in 100 
consecativc patients (all ~70 years old) undergoing acces- 
sory pathway ablation using rxiiofrequency energy (4). 
These patients comprised the control group (Table 3). The 
sludy group ws significantly older than the conlral group 
(72.7 f 2.8 vs. 31.0 f 15.7 yews, p = O.OGIII). In addition, 
the study group received significanlly more antiarrbythmic 
medications (4.1 ? 0.8 vs. 2.0 t 1.5. D = O.WJl). There were 
tta differences with respect to gender. ejection fraction, 
number of radiofrequency applications required or saccess 
between the two groups. However, there were significantly 
mare complications in the study graup (22% vs. 4%, p = 
0.02). Spcciticzally. I (2%) of the 60 younger and 2 (25%) of 
the 8 oldet patients with!-’ ,._ed accessory pathways had a 
cardiac perforation (p = O.MS). 
Atrial flutter &Mon. Atrial flutter was successfully ab- 
lated in all four patients, with a mean of 11.3 + 6.3 
mdiofreauency armlications. The site of successful ablation 
was past&ose~t~ in three patients and ponteralateral in one. 
One patient, who also underwent intracardiac ultrasound 
imaging that required the insertion of an additional IOF 
femoral sheath (91, developed a deep vemus thrombosis. 
This patient war treated with intravenous and then oral 
anticoagulant agenis and made an uneventful recovery. 
During a-follow-up 69.0 t 4.2 months (range 5 to ISI. 
na patient required antiarrbyihmic therapy. and there were 
na arrhythmia recurrences. 
Atrial tubyardh &htia. In one patient the atrial 
tachycurdia focus was mapped to the base of the right atrial 
a~wndwe. Endowdial activstian at this site preceded the 
s&cc p wave by 60 ms. Atrial tachycardii w& temdnated 
during the fifth mdiafreqaeney energy applicatian and re- 
mained nanindaciblc in the presence and absence of isopro- 
terenol. Tkre were no complications. The patiant has 
remained arrhythmia free for 9 months. with no anttifih- 
rnic mediation. 
Holpw~=d=ww looIl virib. The ““nl- 
ber af arrhythmia-related ho&l admissions and emer- 
gency mom visits per year after Ibe ablation procedure were 
signiCcwtly redaced cantpzed witb the I to 2 yeats before 
ablation in each patient grasp gable 4). Spcifically. 0.4 ? 
1.0 versus 3.7 2 2.9 (D = 0.00011 in wtients uadergaing 
complete AV juncliona.i ablation, 0 VC&IS 4.6 + 1.9ip i 
O.wOtl in Datients underrminn AV nade mcdiliwtion. 0.4 f 
1.0 V&US 3.3 2 2.9 (; s-0.01) in patients at&q&g 
accessory pathway ablation and 0 ~ersas4.4 2 4.2 (pi 0.05) 
in patients undergoing atrial tachycardht ar atrial flutter 
ablation. 
r3i%?ussion 
Ruaik. Although B small number of elderly patients 
undergoing radiofrequency catheter ablatian for the treat- 
ment of supwentricalar arrhythmias have been included in 
pwiaus descriplions of ;Iblation praceduras (2.3.10-14). 
this is the first report to evaluate the safety and etlicacy of 
radiifrequency catheter ablation ~pecitically in a large graup 
of elderly patients. F’roccdural end paints were achieved in 
61 of 68 ablation procedures. resulting in an ovemll success 
rate of 98.5%. There were DO procedure-related or early 
deaths. The overall comr4ication rate was 7.4%. and only 
one patient (MS) had k&g.term sequelae (permanent car- 
diac pacing for complete heart block). At a mesn fallow-up 
of 22.1 f 12.9 months (range 5 to 52). 63 (N%) of67 patients 
were alive, with no an&rhythmic agents for the treatment 
of their presentiog arrhythmia. 
Complieatitms. Elderly patients undergoing complete AV 
junctional ablation and AV node modification had a low 
complication rate, similar to that in younger patients. How- 
ever. we found a higher incidence of cardiac perforation in 
older patients undergoing ablation of left-sided accessory 
pathways. Although we were unable to determine the cham- 
her perfotaued, we suspect that the right ventricle was 
involved. In one patient. technical difficulties led to exten- 
sive manipulation of the right ventricular catheter. In sn- 
orher patient, the lack of accumulation of peticardial bled 
made oafomtion of the lefl atrium less likely. A small 
quickly L response to ventricular contraction, as opposed to 
continued leaking t?om atrial chambers. It is possible that 
perfotadons occur more often than suspected and that they 
become clinically manifest in left-sided procedures because 
of the adminislration of heratin. In addition. an age-related 
increase in stiffness and a decrease in thickness of the right 
ventricular wall may increase the risk of perforation in the 
elderly (15.16). Therefore, although care should always be 
taken when manipulating catheters in the heat. this is 
espceially uue in elderly patients. 
A pulmonary embolos occured in one patient (I 5%). We 
do not routinely petfonn anticoagulation in patients under- 
going tight-sided procedures. Anticoagulation would io- 
emase Ihe risk of bleeding and cardiac tampontide. Further 
study is required to determine whether the benefits of 
anticoa&tion would outweigh the risks. 
swpnve&kahrta&yardbil4thedtkrly. Thecobortof 
p4atls with paroxysmal suptaventticular tachycardias 
other than atrial fibrillation was relatively healthy with good 
IeH ventrietdar function. However, episodes of txhycdia 
were assaekted with severe symptoms in most patients. 
This apparent inconsistency can be explained by age-related 
SbmKmnlities in diastolic relaxation and Mittg, resulting in a 
tachycadia-iiuced reduction in cardiac output, even in the 
absence of d&ax (17~201. In addirion. because of axe- 
related impairment if cardiovascular reflexes and an 1. 
erased likelihood of cerebmvawtlar disease. elderly pa- 
tieas are more likely IO have tt critical reduction in cerebral 
Row during tschycardic episodes ;,?I). 
Taehywdic episodes we not only less well tolerated in 
elderly &ent.s. they appear to occur more frequently. In a 
recent study advancing age was found to be the most 
impoztanl factor in determining the frequency of spontane- 
otts episodes of symptomatic atrial fibrillation and paroxys- 
mal supaventricular tachycardis (22). Each I&year incre- 
ment in age was associated with a 25% decrease in the time 
10 lirst reewrettee. Therefore, a 70-year old patient would 
have twice the frequency of arrhythmic events as a @year 
old @e.nt. 
&cause of age-related physiologic changes and a higher 
likelihood ofcoexisting diseases, ant&rhythmic agents may 
be kss well tolerated and produce more toxicity in elderly 
patients (Table 5). These physiologic changes pmducc alter- 
ations in the volume of distribution, protein binding and 
clearance of antiarrhythmic agents. leading to increased risk 
of tonicity (23-26). In addition, impaimtent of cardiovascular 
reflexes and co&sting myocwdii dysfunction potentiatas 
the hypotensivc effects of agents with vasodilating and 
nep&ive ionotmpic propelties (?I). In addition. it has been 
postulated that myocardial sensitivity to antiarrhythmic 
agents may be altered in the elderly (27-29). 
Despite these findings there appears to be a reluctaoce 10 
offer invasive treatment options to elderly patients with 
symptomatic supraventricuiar tachycardia.. In our series, 
elderly patients with accessory pathway mediated end AV 
node reentrant tachyctudia received significantly more anti- 
arrhythmic agents than younger patients. Although this may 
be due in part to a longer history of tachycardia and limited 
treatment options in previous yeas, it also may be related to 
a reluctance to subject elderly patients to inwive proce- 
dures. 
The number of arrhythmia-related hospital admissions 
and emergency mom visits per year were dramatically 
decreased after ablation in all patient groups. Given the cost 
of repeated hospital admissions. emergency room and clinic 
visits and long-tcnn antiarrhythmic therapy. catheter abla- 
tion may be a cost-effective as well as safe. and efficacious 
treatment option. 
~tudyliiitatiiaa. Themajorlimitationofthisstudyisthe 
small number of patients in some of the subgroups. Although 
ctttheter ablation appeared to be an effective and safe treat- 
ment option for elderly patients in this series, further study 
is required of the more infrequent procedures. In addition, 
although in these patients a signiticant number of antiar- 
rhvthmic awnis failed. they rcquired significantly less health 
c&e after ablation. However, this study did not compare 
medical and ablative therapy. A carefully designed, random- 
ized, prospective study is required to resoiie this point. 
Conehuiotts. In this series, radiofrequency catheter abla- 
tion appears to be an effective and safe treatment option in 
elderly patients (270 years old) with a variety of symptom- 
atic. drug-resistant supraventricular tachycardias. Because 
of the high incidence of severe symptoms associated with 
tachycardic episodes and the intolerance and toxicity asso- 
ciated with antiarrhythmic medications in this group, cathe- 
ter ablation might be considered an early rather than a last 
resort lreatment option. Further prospective, raudmnized 
trials are needed tohemonstrate whether medical or ablative 
therapy is most beneficial with regard to efficacy, toxicitg 
and MS,. 
